0001346302-16-000002.txt : 20161230 0001346302-16-000002.hdr.sgml : 20161230 20161230114217 ACCESSION NUMBER: 0001346302-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161230 DATE AS OF CHANGE: 20161230 EFFECTIVENESS DATE: 20161230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-254861 FILM NUMBER: 162076901 BUSINESS ADDRESS: STREET 1: 3208 RED RIVER STREET STREET 2: STE 300 CITY: AUSTIN STATE: TX ZIP: 78705 BUSINESS PHONE: 512-534-8340 MAIL ADDRESS: STREET 1: 3208 RED RIVER STREET STREET 2: STE 300 CITY: AUSTIN STATE: TX ZIP: 78705 D/A 1 primary_doc.xml X0707 D/A LIVE 0001346302 XERIS PHARMACEUTICALS INC 3208 RED RIVER STREET STE 300 AUSTIN TX TEXAS 78705 512-498-2670 DELAWARE None None Corporation true Douglas Baum 3208 Red River Street Suite 300 Austin TX TEXAS 78705 Executive Officer Director Steven Prestrelski 3208 Red River Street Suite 300 Austin TX TEXAS 78705 Executive Officer Poul Strange 3208 Red River Street Suite 300 Austin TX TEXAS 78705 Executive Officer Cary McNair 3208 Red River Street Suite 300 Austin TX TEXAS 78705 Director Navneet Puri 3208 Red River Street Suite 300 Austin TX TEXAS 78705 Director Robert Faulker 3208 Red River Street Suite 300 Austin TX TEXAS 78705 Director Jonathan Rigby 3208 Red River Street Suite 300 Austin TX TEXAS 78705 Director Pharmaceuticals Decline to Disclose 06b true 0001346302-16-000001 2015-12-31 true true false 0 49999995 45005982 4994013 Series C Preferred Stock false 48 0 0 0 false XERIS PHARMACEUTICALS INC /s/Douglas Baum Douglas Baum President & Chief Executive Officer 2016-12-29